Ergomed Signs Co-Development Collaboration Agreement with Genzyme Corporation to Develop Tasidotin in Oncology

 
  Welcome to ERGOMED.  
 

ERGOMED is an established international clinical development company offering contract clinical
research and co-development partnerships to biotechnology and pharmaceutical companies
world wide.

   

ERGOMEDS's approach to clinical
research ensures effective patient
recruitment reducing time and cost
of clinical trials.

 

Our expertise and depth of experience in the clinical development process complements the drug discovery and development capabilities of our partners.

 

ERGOMED has a dual business model offering standard clinical trial management contracts and also co-development partnerships to share the risk and rewards of clinical development.

         

 
 

Bio-Europe Spring 2010, Barcelona
March 8-10, 2010

BioTrinity 2010, Newbury (UK)
April 12-14, 2010




[more Events]

 
 

 


© 2007 ERGOMED GmbH - Otto-Volger-Straße 9b - 65843 Sulzbach/Ts. (Frankfurt) - Germany - Phone +49 (0) 6196 / 90754-0 - Fax: +49 (0) 6196 / 90754-69
Legal Information and Notices | Company | Management | Contact | Jobs